Background: Intramarrow penetration (IMP) is often incorporated in regenerative periodontal surgical procedures. However, the actual benefits of adding IMP to such a procedure remain undocumented. The purpose of this randomized controlled trial was to investigate the contribution of IMP to the outcomes of open-flap debridement (OFD) treatment of intrabony defects.
I
ntrabony defects associated with periodontal pockets represent the anatomic sequelae of the apical spread of plaque in the course of periodontitis. 1 Such defects are risk factors for periodontitis progression and additional loss of attachment if left untreated. 2 Because intrabony defects are common in periodontitis, 3, 4 there is considerable interest in approaches that will convert such defects, at risk for disease progression, to easily maintainable shallow probing sites. This can be achieved by either resective [5] [6] [7] or regenerative [8] [9] [10] [11] [12] approaches, with the latter considered the ideal treatment.
Among the various surgical techniques used to achieve the ideal biologic conditions required for periodontal regeneration, open-flap debridement (OFD) or access flap surgery was among the earliest procedures used [13] [14] [15] and has been shown to result in successful treatment of intrabony defects. 16 OFD has been traditionally included as the control procedure in clinical trials evaluating regenerative techniques, such as guided tissue regeneration (GTR), 17, 18 and use of biologic factors, including enamel matrix derivative. 11 Even when used as the control procedure, OFD resulted in significant clinical benefits. 17, 18 According to a recent systematic review, 16 the average clinical attachment level (CAL) gain obtained with OFD alone was 1.65 mm, average probing depth (PD) reduction was 2.80 mm, gingival recession (REC) increase was 1.26 mm, and bone gain at 12 months was clinically 1.04 mm and radiographically 0.95 mm. However, the reported clinical outcomes of OFD may vary, showing variability attributed to surgical technique (e.g., papilla preservation) and to patient-and operator-related factors. 16 Therefore, there is opportunity to improve the predictability of OFD in the treatment of intrabony defects.
Several authors have advocated the use of intramarrow penetration (IMP), also known as decortication, as a means to improve the local blood vessel and progenitor cell supply and, consequently, the outcomes of surgical procedures used to treat intrabony defects. [19] [20] [21] [22] [23] However, the clinical benefits of this adjunctive procedure remain to be established. Specifically, the adjunctive use of IMP in the treatment of intrabony defects by OFD has not been investigated in clinical trials. Therefore, the purpose of this study is to investigate, using a randomized controlled trial (RCT) approach, the contribution of IMP to the clinical and radiographic outcomes of OFD treatment of intrabony defects.
MATERIALS AND METHODS

Study Design
This was a randomized controlled trial. Eight weeks after completion of initial (non-surgical) periodontal therapy, reevaluation was performed to assess specific sites and to determine eligibility of periodontitis patients, whose previous treatment plan was to receive OFD for treatment of intrabony defects. In each individual, one intrabony defect was selected, without stratification by tooth type or location. If more than one defect was present in the same participant, the deepest at the radiographic and clinical examinations was selected. Patients were randomized for treatment with either OFD alone (OFD; control group) or OFD plus IMP (OFD + IMP; test group). Clinical and radiographic assessments were performed at baseline (before surgery) and at 12 months postoperatively. The study design outline is presented in Figure 1 . The study was conducted according to the 1975 Helsinki Declaration, as revised in 2000, and was approved by the Ethics Committee of the Catholic University of Sacred Heart, Rome, Italy (Protocol P/176/CE/2009). All participants provided written informed consent after receiving explanations on study objectives and procedures.
Enrolled patients were randomized into test or control group, with a 2:1 ratio, by blocked randomization, according to a table prepared by the study statistician (C Lajolo). The 2:1 allocation ratio was chosen to maximize the number of patients receiving test treatment. The surgeon was informed of the treatment allocation just before suturing.
Clinical and radiographic measurements were performed by a sole trained examiner (GVO) with >15 years of experience in periodontal diagnosis who was not involved in delivery of surgical or maintenance care and masked to treatment allocation and treatment staging.
Study Population
Participants were recruited among patients referred to the Department of Periodontology of the Catholic University of Sacred Heart for the treatment of moderate-to-severe chronic periodontitis (CP), diagnosed according to the criteria established at the 1999 international workshop for the classification of periodontal diseases and conditions. 24 Participants included 20 males and 21 females, aged 36 to 65 years (mean age: 52.3 -6.9 years) and were enrolled from January 2009 to October 2010. Eligibility criteria were: 1) aged ‡28 years; 2) no medical conditions interfering with periodontal health or wound healing; 3) no allergies to study medications; 4) nonsmoker or smoking <5 cigarettes/day; 5) presence of one 2-or 3-wall intrabony defect with radiographic depth ‡4 mm; and 6) completed Study design. SRP = scaling and root planing; OHI = oral hygiene instructions; SPT = periodontal maintenance; PI = plaque index; BOP = bleeding on probing; CBL = cemento-enamel junction to clinical base of defect; rDD = radiographic defect depth; rDW = radiographic defect width; ANG = radiographic defect angle.
etiologic periodontal therapy (oral hygiene instructions and scaling and root planing under local anesthesia). At reevaluation, performed 8 to 12 weeks after completion of etiologic therapy, patients with a good oral hygiene standard (full-mouth plaque score <20%) 25 and low levels of residual infection (full-mouth bleeding score <20%), 9 having one interproximal area meeting the following criteria, were recruited. Tooth/defect eligibility criteria were: 1) PD ‡5 mm and CAL ‡5 mm, associated with a 2-wall, 3-wall, or combined 2-to 3-wall intrabony defect ‡3 mm deep (assessed by transgingival probing and to be confirmed after flap elevation); 2) defect not extending to a root furcation area; 3) tooth mobility £1; tooth and adjoining teeth testing vital and without symptoms or signs of endodontic involvement; 4) tooth and adjoining teeth free of caries or inadequate restorations; and 5) absence of non-working interferences.
Clinical Parameters
Clinical parameters were assessed using a manual probe ‡ and recorded to the nearest millimeter. Defect-specific assessments were made at the deepest point of the defect. The cemento-enamel junction (CEJ) or a restoration margin was used as fixed reference point.
For each patient, the following parameters were assessed on six sites per tooth from all teeth: 1) PD; 2) CAL; 3) REC; 4) bleeding on probing (BOP); 5) plaque index (PI), with use of disclosing solution; and 6) keratinized tissue width (KTW), which is the distance from the gingival margin to the mucogingival junction.
CEJ to clinical base of defect, designated as CBL, was assessed by means of a no. 25 endodontic file under local anesthesia, using a rubber stop and an endodontic ruler. The parameters recorded during surgery are reported below.
Radiographic Parameters
Standardized periapical radiographs § were obtained preoperatively and at follow-up using the longcone paralleling technique. All radiographs were obtained using the same equipment, film, exposure, and development conditions. Radiographic defect depth (rDD), defined as the distance from the projection on the root surface of the most coronal point of the residual bone crest to the bottom of the defect, and radiographic defect width (rDW), defined as the distance from the most coronal point of the residual bone crest to the root surface, were measured using a caliper and recorded to the nearest millimeter. The bottom of the defect was defined as the most coronal point at which the periodontal ligament (PDL) showed continuous width. 26 Radiographic measurements were corrected to account for magnification (4%) by equipment used, i using as reference a metal sphere of known diameter. The radiographic defect angle (ANG), defined by a line tangential to the root surface and a line connecting the bottom of the defect to the most coronal part of the crest next to the adjacent tooth, was also measured. 26 
Surgical Procedures
After administration of local anesthesia, mucoperiosteal flaps were elevated using a simplified or modified papilla-preservation flap design. 27, 28 Defects were thoroughly debrided using curets and ultrasonic scalers.
The following clinical parameters were then recorded at the deepest point: 1) CEJ to the alveolar bone crest (CEJ-BC); 2) CEJ to the surgical bottom of the defect; 3) defect depth, measured as the alveolar bone crest to the surgical bottom of the defect; and 4) defect width, measured as the distance from the root surface to the most coronal extension of the alveolar crest and 5) number of defect walls. Preoperative supracrestal soft tissue was subsequently calculated by the formula (CEJ-BC) -REC. 29 Data related to these parameters (not reported here) will be the subject of separate analyses and will be reported elsewhere.
After debridement and intraoperative recordings, the control group was treated as follows. Periosteal releasing incisions were performed to ease flap repositioning and ensure primary closure, and modified horizontal mattress sutures ¶ were placed. In the test group, the intrabony defect cortical walls were penetrated using a round carbide bur # (1-mm diameter) to reach the marrow space: multiple perforations were performed not closer than 1 mm from each other and deep enough to obtain bleeding from the spongiosa (Fig. 2 ). Flaps were than closed in the same manner as in the control group. No dressing was used.
Postoperative Protocol
Patients were prescribed antibiotics (1 g amoxicillin** twice daily for 6 days, starting the day before surgery) and antimicrobial gel (1% chlorhexidine gel, twice daily for 3 weeks). Sutures were removed 1 week postoperatively. Recall appointments were scheduled weekly during the first postoperative month and every 3 months thereafter for the duration of the study. At each recall appointment, ‡ UNC-15 probe, Hu-Friedy, Chicago, IL. § Kodak Ultraspeed DF58, Eastman Kodak, Rochester NY. supragingival debridement and coronal polishing were performed, and oral hygiene instructions were reinforced if necessary. At the 9-and 12-month recall visits, careful subgingival instrumentation was also performed. BOP and PI were assessed at the 6-and 12-month visits. All the parameters were collected before each maintenance procedure.
Statistical Analyses
The defect was the unit of analysis. Descriptive statistics were calculated for demographic, clinical, and radiographic parameters, and data are presented as mean -SD, range, or percentages depending on the variable nature (parametric or non-parametric). Quantitative variables were tested for normality (Shapiro-Wilk test). Differences between groups were analyzed by Kruskal-Wallis test (non-parametric variables) or two-tailed analysis of variance (ANOVA) (parametric variables). Differences in discontinuous variable distribution were assessed by x 2 or Fisher exact test. Comparison between groups was made at baseline to detect any possible differences at that time point; intragroup comparisons were performed between baseline and 12-month data to assess procedure efficacy. An analysis of covariance (ANCOVA) test was used to detect differences between groups at 12 months: gain in CBL and gain in rDD were the primary outcomes. Baseline CBL, baseline ANG, baseline CAL, number of defect walls, and jaw distribution (maxillary/ mandible) were used in the ANCOVA model as covariates for gain of bone sounding; baseline rDD, baseline ANG, baseline CAL, number of defect walls, and jaw distribution (maxillary/mandible) were used in the ANCOVA model as covariates for gain in rDD. Significance was set at No statistically significant differences between treatment groups (P >0.05).
Demographics of Study Population
Parameter OFD (n = 13) OFD + IMP (n = 28) Total (N = 41)
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Crea, Deli, Littarru, Lajolo, Vittorini Orgeas, Tatakis P = 0.05. Statistical analysis was performed using commercial software. † †
RESULTS
Study Population
Of 60 screened patients, 42 eligible and consented participants were randomized into test (n = 28) or control (n = 14) groups, and 41 completed the study. Eighteen individuals (six in the control group and 12 in the test group) were excluded for defect not meeting criteria at surgery (1-to 2-wall defect, n = 10; intrabony defect depth <3 mm, n = 5; incipient furcation involvement, n = 2; root fracture, n = 1). One patient (control group) did not complete the study for failure to attend postoperative study visits. Patient demographics and defect characteristics are reported in Table 1 . No demographic or defect-distribution differences were observed between the two treatment groups at baseline (Table 2) .
Clinical and Radiographic Parameters
Baseline and 12-month parameters are reported in Table 3 . At baseline, there were no statistically significant differences between control and test groups for any of the recorded parameters. Intragroup comparisons revealed that the control group experienced statistically significant improvements in PD (P <0.001), CAL (P <0.01), CBL (P <0.05), ANG (P <0.01), and rDD (P <0.001). The test group experienced statistically significant improvements in PD (P <0.001), CAL (P <0.001), CBL (P <0.001), rDW (P <0.001), ANG (P <0.001), and rDD (P <0.001). The changes in clinical and radiographic parameters, comparing baseline to 12-month values, are reported in Table 3 .
Intergroup comparisons for CBL and rDD after stratification for tooth type (anterior, posterior), jaw, and number of walls are summarized in Table 4 .
When comparing the added benefit of IMP between maxilla and mandible, a greater reduction of rDD was observed for mandibular sites, which showed more than double radiographic bone fill when treated with the test procedure (control: 1.40 -1.82 mm; test: 3.32 -3.39 mm).
The prevalence of CAL gain ‡2 mm was significantly greater (P = 0.024) in the test group (93% of sites) compared with the control group (62% of sites) ( Table 5 ).
DISCUSSION
The aim of this RCT is to assess the effect of the addition of IMP to OFD during the treatment of intrabony defects in patients with CP. The addition of IMP improved both clinical and radiographic bonehealing parameters. To the best of the authors' knowledge, this is the first RCT to examine the use of IMP in conjunction with any periodontal surgical procedure.
OFD, both without and with IMP, resulted in significant reduction in PD and gain in CBL and CAL. Radiographically, both treatments resulted in significant ANG and rDD decreases. These results are consistent with the reported outcomes of studies on OFD efficacy as surgical therapy for intrabony defects. 16 Decortication of the defect walls by means of a round carbide bur, after careful debridement, improved the clinical and radiographic outcomes of OFD; specifically, addition of IMP resulted in greater clinical (CBL) and radiographic (rDD) bone fill, which was significant both statistically and clinically. Based on these clinical and radiographic outcomes, IMP significantly enhances the OFDassociated bone regeneration; however, characterization of the true nature of the tissue that filled the defects will require histologic assessment. Moreover, it should be noted that the 2-and 3-wall defects included in the present study are generally considered to have a positive response to regenerative treatment; therefore, the potential contribution of IMP to the treatment of defects with less favorable anatomy (i.e., 1-wall or 1-to 2-wall defects) remains to be investigated.
Starting in the 1970s and 1980s, several authors reported the clinical application of IMP in conjunction with regenerative periodontal surgical procedures; No statistically significant differences between groups (P >0.05). See text for statistical models. All parameters are measured in millimeters and given as mean -SD unless otherwise noted. † † Stata v.8.0, StataCorp, College Station, TX.
specifically, IMP has been incorporated in OFD, 19, 22, 23 bone grafting, 20, 21 and GTR 23 procedures used to treat intrabony defects. In the studies in which it was used as part of a regenerative procedure to treat intrabony defects, IMP was applied either at the discretion of the surgeon 20, 21 or only when there was no bleeding in the defect 22 or in all defects. 23 Furthermore, the studies differ in the manner IMP was performed; operators reported using curets or explorers, 19 a round bur, 23 or provided no specific information. [20] [21] [22] The above clinical trial designs render difficult, if not impossible, any objective assessment of the contribution of IMP to the observed outcomes. With the exception of the study by Sepe et al., 20 who reported that intrabony defects treated with bone graft and IMP tended to have greater bone fill than defects treated with bone graft alone (there was no statistically significant difference between the two groups), none of the previous studies included analysis of IMP outcomes. The results of the present trial provide the first evidence supporting the incorporation of IMP in a surgical procedure (OFD) used to treat intrabony defects. In this context, it should be noted that studies to determine what could the ideal size, depth, and pattern of IMP are lacking for any surgical procedure in which IMP has been incorporated. IMP has been more recently incorporated in root coverage procedures using coronally advanced flap, 30, 31 GTR, [30] [31] [32] [33] or connective tissue graft 34 approaches to treat REC defects. The universal inclusion of IMP in the above protocols precludes analysis of the possible contribution of IMP to the outcomes of what are, for the most part, soft tissue procedures.
Use of IMP has also been advocated as part of guided bone regeneration (GBR) or ridge augmentation procedures. 35, 36 The literature on IMP and GBR was reviewed by Greenstein et al., 37 who concluded that the lack of any controlled clinical trial on the topic and the existing conflicting information make it impossible to definitively determine the value of IMP as part of a GBR procedure. However, the authors also concluded that, given the lack of any negative effects associated with IMP, the inclusion of IMP as part of a GBR procedure is not contraindicated. 37 Last, IMP has been described as an integral part of the periodontally accelerated orthodontic tooth movement, a procedure that combines interradicular corticotomies, IMP, and bone grafting before initiation of orthodontic tooth movement. 38, 39 The contribution of IMP to the outcomes of this procedure has not been specifically assessed; however, animal studies 40, 41 and human case reports 42 suggest that the interradicular corticotomies alone are likely sufficient for this procedure to be effective. This, in turn, suggests that localized disruption of alveolar bone structural integrity (whether by IMP or linear corticotomies) is sufficient to generate the desired metabolic response.
To the best of the authors' knowledge, the present trial provides the first clinical evidence in support of the use of IMP in conjunction with a periodontal surgical procedure, with results indicating that addition of IMP to OFD can provide significant benefits in terms of hard-tissue healing and predictability of ‡2 mm of CAL gain in intrabony defects (Table 5) . A limitation of the present study is the lack of histologic assessment; ethical considerations precluded the incorporation of biopsies (whether block biopsies or trephine specimens) or reentry procedures. However, bone sounding has been shown to be accurate in estimating hard tissue reconstruction, 43 thus eliminating the need for reentry procedures.
Animal studies indicate that IMP leads to localized, broad enhancement of cancellous bone turnover, as well as enhanced PDL activity; 41, 44 these findings suggest that the observed tissue responses are a manifestation of Frost's regional acceleratory phenomenon. 45 Although the molecular mechanisms responsible for the IMP-induced responses are not fully elucidated, recent animal data suggest that increased expression of receptor activator of the nuclear factor-kB ligand is a significant element of the process; 41, 46 such evidence introduces the possibility of future pharmacologic applications. Evidence from a recent animal study indicates that IMP alone results in increased bone formation during the later stages of alveolar bone healing; 41 importantly, the combination of a full-thickness flap and IMP procedure on intact alveolar bone did not result in any pathologic changes to bone quality or quantity, once homeostasis was reestablished. 41 In the context of intrabony defect treatment, besides the documented increases in bone turnover, IMP might also favor clot formation and maturation, which is considered a key factor during periodontal regeneration. 47 
CONCLUSIONS
The results of the present study suggest that addition of IMP to an OFD procedure used to treat intrabony defects could result in significant improvement of clinical outcomes in well-maintained periodontal patients, with particular benefits, in terms of vertical bone fill, for mandibular defects. Given that IMP is easy to implement and adds minimal time, cost, and risk to a regenerative procedure, there should be no barriers to its routine incorporation in the surgical treatment of intrabony defects. 
